Drug intelligence / Profile preview

Isoferulic acid

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Isoferulic acid is a naturally occurring phenolic compound classified as a hydroxycinnamic acid derivative. It is found as a major active ingredient in the rhizome of Cimicifuga heracleifolia and other plants. Isoferulic acid exhibits multiple biological activities, including anti-inflammatory, antioxidant, antiviral, antidiabetic, and anticancer effects[1][4][6]. Mechanistically, it has been shown to inhibit capsule synthesis in Klebsiella pneumoniae by reducing capsular polysaccharide production[4], induce G2/M-phase cell cycle arrest and apoptosis in leukemia cells via inhibition of Akt/mTOR signaling[6], and activate adrenergic receptors[1]. Its broad pharmacological profile makes it an experimental candidate for various therapeutic applications.

Other names
hesperetic acid3-hydroxy-4-methoxycinnamic acidisoferulate
02

Targets

GT-1 (Capsule polysaccharide synthesis enzyme GT-1)GALNT (Polypeptide N-acetylgalactosaminyltransferase family (GALNT family))ADRA1A (α1A)

Beyond the preview

Go deeper on Isoferulic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isoferulic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call